Table 1.
Participant Characteristics (N = 35).
| Mean | Standard Deviation | Range | |
|---|---|---|---|
| Demographic Characteristics | |||
| Age (Years) | 18.80 | 1.73 | 15 – 22 |
| Gender (M/F) | 23/12 | ||
| Handedness (R/L) | 27/1 | ||
| Race (White/Non-White) | 23/11 | ||
| Parental Education (Years) | 15.32 | 1.97 | 12 – 18 |
| WRAT Sum IQ | 111.31 | 12.55 | 87 – 145 |
| Clinical Characteristics | |||
| Antipsychotic Medications (Y/N) | 8/27 | ||
| Chlorpromazine Equivalents (N=8) | 119.79 | 74.79 | 50 – 250 |
| Positive Symptoms | 12.23 | 5.80 | 0 – 23 |
| Negative Symptoms | 9.17 | 7.12 | 0 – 24 |
| Disorganized Symptoms | 5.63 | 4.07 | 0 – 12 |
| Clinical Insight (SUMD) | |||
| Awareness of Mental Disorder | 2.14 | 1.42 | 0 – 5 |
| Awareness of Medication Effects | 1.00 | 1.39 | 0 – 4 |
| Awareness of Social Consequences | 1.74 | 1.56 | 0 – 4 |
| Current Clinical Insight | 4.89 | 3.13 | 0 – 12 |
Note, WRAT, Wide Range Achievement Test; SUMD, Scale to Assess Unawareness of Mental Disorder; Symptom severity was assessed with the Structured Interview of Prodromal Syndromes; Chlorpromazine equivalents were computed only for those individuals taking antipsychotics